Markets:

Overview

News

Currencies

International

Treasuries

Cel-Sci Corporation Common Stock (NY:CVM)

1.567 -0.073 (-4.48%)

Delayed Quote Updated: 11:55 AM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cel-Sci Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Mid-Day Market Update: Crude Oil Down Over 1%; Intellia Therapeutics Shares Jump ↗

June 28, 2021

Midway through trading Monday, the Dow traded down 0.52% to 34,253.86 while the NASDAQ rose 0.72% to 14,463.56. The S&P also fell, dropping 0.01% to 4,280.50. The U.S. has the...

Via Benzinga

Topics Stocks

44 Stocks Moving In Monday's Mid-Day Session ↗

June 28, 2021

Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy. Marin Software...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; Perion Network Boosts FY21 Outlook ↗

June 28, 2021

Following the market opening Monday, the Dow traded down 0.30% to 34,329.01 while the NASDAQ rose 0.60% to 14,446.74. The S&P also rose, gaining 0.04% to 4,282.58. The U.S....

Via Benzinga

Topics Stocks

CEL-SCI's Immunotherapy Achieves Survival Benefit Of 14% Exceeding Pre-Defined 10% In Head & Cancer Patients ↗

June 28, 2021

CEL-SCI Corporation (NYSE: CVM) has announced results from its Phase 3 study for its immunotherapy Multikine for advanced previously untreated squamous cell...

Via Benzinga

CEL-SCI’s Multikine® Immunotherapy Produces Significant 14.1% 5-Year Survival Benefit (62.7% Vs 48.6%) in the Group Receiving Surgery Plus Radiotherapy in a Landmark Head and Neck Cancer Phase 3 Study

June 28, 2021

From CEL-SCI Corporation

Via Business Wire

24 Stocks Moving in Monday's Pre-Market Session ↗

June 28, 2021

Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) rose 28.9% to $114.49 in pre-market trading. Intellia Therapeutics and Regeneron Pharmaceuticals disclosed positive interim...

Via Benzinga

CEL-SCI Corporation Invites Participants to Pre-Submit Questions for Annual Shareholder Meeting

June 25, 2021

From CEL-SCI Corporation

Via Business Wire

Cel-Sci Stock Shows Market Leadership With Jump To 81 RS Rating ↗

June 17, 2021

Cel-Sci sees its Relative Strength Rating hit the 80-plus level.

Via Investor's Business Daily

CEL-SCI Announces the Closing of $31.7 Million Bought Deal Offering

June 11, 2021

From CEL-SCI Corporation

Via Business Wire

28 Stocks Moving in Wednesday's Pre-Market Session ↗

June 09, 2021

Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) rose 72.4% to $3.81 in pre-market trading following Zacks article 'AEMD: First Ever In Vivo Removal Of COVID Virus From...

Via Benzinga

62 Biggest Movers From Yesterday ↗

June 10, 2021

Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares surged 388.2% to close at $10.79 on Wednesday in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID...

Via Benzinga

CEL-SCI Stock Drops After Raising $37.1M Via Secondary Equity Offering ↗

June 09, 2021

CEL-SCI Corporation (NYSE: CVM) has increased the size of its previously announced capital raise offering to 1.4 million shares, up from 1 million shares, at...

Via Benzinga

48 Stocks Moving In Wednesday's Mid-Day Session ↗

June 09, 2021

Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares jumped 371% to $10.41 in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An...

Via Benzinga

CEL-SCI Increases Previously Announced Bought Deal to $31.7 Million

June 08, 2021

From CEL-SCI Corporation

Via Business Wire

CEL-SCI Announces Bought Deal Offering

June 08, 2021

From CEL-SCI Corporation

Via Business Wire

Can You Count on This Popular Reddit Cancer-Treatment Stock? ↗

June 05, 2021

Big news is coming for CEL-SCI, and we don't know which way the stock will move.

Via The Motley Fool

Cel-Sci Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating ↗

May 27, 2021

Cel-Sci stock saw an improvement to its Relative Strength Rating on Thursday, rising from 79 to 87, making the stock a potential watchlist candidate.

Via Investor's Business Daily

CEL-SCI Corporation Reports Second Quarter Fiscal 2021 Financial Results

May 18, 2021

From CEL-SCI Corporation

Via Business Wire

58 Biggest Movers From Yesterday ↗

May 18, 2021

Gainers Peabody Energy Corporation (NYSE: BTU) shares gained 32.3% to settle at $8.60 on Monday. Nuvve Holding Corp. (NASDAQ: NVVE) shares jumped 30.9% to close at $10.80 on...

Via Benzinga

Struggling Big Tech Puts More Pressure on Markets ↗

May 17, 2021

The Dow Jones Industrial Average is off 163 points midday as Big Tech's march lower resumes, pouring cold water on the broader market.

Via Talk Markets

Topics Stocks

40 Stocks Moving In Monday's Mid-Day Session ↗

May 17, 2021

Gainers Nuvve Holding Corp. (NASDAQ: NVVE) shares surged 22.2% to $10.08 after the company announced an agreement with Evolve Transition Infrastructure and Stonepeak to purse a $...

Via Benzinga

Biotech Cel-Sci Stock Joins Rank Of Stocks With RS Ratings Over 90 ↗

April 28, 2021

Cel-Sci shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

44 Biggest Movers From Yesterday ↗

April 23, 2021

Gainers KnowBe4, Inc. (NASDAQ: KNBE) shares jumped 50.9% to close at $24.14 on Thursday after the company priced its IPO at $16 per share. Neuropace, Inc. (NASDAQ: NPCE) shares...

Via Benzinga

Topics Initial Public Offering

30 Stocks Moving In Thursday's Mid-Day Session ↗

April 22, 2021

Gainers Teradata Corporation (NYSE: TDC) shares jumped 28.6% to $51.29 after the company raised its Q1 earnings guidance. SeaChange International, Inc. (NYSE: SEAC) gained 19.6...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.